Migraine
Not recruitingStudy on Atogepant for Preventing Menstrual Migraine in Women
Study on Atogepant for Preventing Menstrual Migraine in Women
Portugal- Participants:18–64 years
- Substances:Atogepant
- Sponsor:AbbVie Deutschland GmbH & Co. KG
Rare diseases
Investigational molecules
Locations
Back to Portugal674 clinical trials in Carnaxide, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on Atogepant for Preventing Menstrual Migraine in Women
PortugalStudy of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia
PortugalStudy to Evaluate the Safety and Effectiveness of Vutrisiran in Patients with Transthyretin Amyloidosis and Heart Disease
PortugalStudy on the Safety and Effectiveness of Inclisiran for Children Aged 6 to Under 12 with Familial Hypercholesterolemia
PortugalStudy of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
PortugalStudy on Edoxaban for Patients with Atrial Fibrillation and Previous Brain Bleeding
PortugalStudy of TX000045 for Pulmonary Hypertension in Heart Failure Patients with Preserved Ejection Fraction
PortugalStudy Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
PortugalStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
PortugalStudy of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections
PortugalStudy on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer
PortugalStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on atherosclerotic cardiovascular disease and heart conditions, including trials evaluating new treatments for hypertrophic cardiomyopathy and pediatric heart failure.
Research aims to reduce major cardiovascular events and improve patient outcomes through novel therapeutic approaches.
Comprehensive research into kidney disorders, with a focus on IgA Nephropathy and innovative treatments for chronic kidney disease. Multiple trials are investigating new therapeutic options for patients with various forms of kidney dysfunction.
Studies aim to improve kidney function and reduce disease progression in patients with various renal conditions.
Advanced research targeting hypertriglyceridemia and related metabolic conditions. Studies focus on novel treatments for patients with severe metabolic disorders and associated cardiovascular risks.
Investigations concentrate on developing targeted therapies to address complex metabolic disorders and their complications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.